Hex:5 HexNAc:5 dHex:1 NeuAc:1

Taxonomy

• Homo sapiens (Human)
• Mus musculus (House mouse)
• Rattus norvegicus (Norway rat)
• Sus scrofa (Pig)
• Gallus gallus (Chicken)
• Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)

Protein

• Alpha-1-antitrypsin / Homo sapiens    P01009
• Alpha-2-HS-glycoprotein / Homo sapiens    P02765
• Alpha-2-macroglobulin / Homo sapiens    P01023
• Alpha-fetoprotein / Homo sapiens    P02771
• Angiopoietin-related protein 6 / Homo sapiens    Q8NI99
• Anoctamin-6 / Homo sapiens    Q4KMQ2
• Asporin / Homo sapiens    Q9BXN1
• Beta/gamma crystallin domain-containing protein 1 / Homo sapiens    Q9Y4K1
• Biglycan / Homo sapiens    P21810
• Cadherin-5 / Homo sapiens    P33151
• Calumenin / Homo sapiens    O43852
• Cartilage oligomeric matrix protein / Homo sapiens    P49747
• Catalase / Homo sapiens    P04040
• CD166 antigen / Homo sapiens    Q13740
• CD44 antigen / Homo sapiens    P16070
• CD59 glycoprotein / Homo sapiens    P13987
• Ceruloplasmin / Homo sapiens    P00450
• Clusterin / Homo sapiens    P10909
• Collagen alpha-1(XII) chain / Homo sapiens    Q99715
• Collagen alpha-2(VI) chain / Homo sapiens    P12110
• Complement c1r subcomponent / Homo sapiens    P00736
• Complement C2 / Homo sapiens    P06681
• Complement C5 / Homo sapiens    P01031
• Corticosteroid-binding globulin / Homo sapiens    P08185
• Decorin / Homo sapiens    P07585
• Dipeptidyl peptidase 1 / Homo sapiens    P53634
• Ectopic P granules protein 5 homolog / Homo sapiens    Q9HCE0
• Ephrin-A3 / Homo sapiens    P52797
• Epidermal growth factor receptor / Homo sapiens    P00533
• Fibrillin-1 / Homo sapiens    P35555
• Fibromodulin / Homo sapiens    Q06828
• Fibronectin / Homo sapiens    P02751
• Glycophorin-A / Homo sapiens    P02724
• Golgi membrane protein 1 / Homo sapiens    Q8NBJ4
• Hemopexin / Homo sapiens    P02790
• Heparin cofactor 2 / Homo sapiens    P05546
• Immunoglobulin epsilon chain c region / Homo sapiens    P01854
• Immunoglobulin gamma / Homo sapiens    P01859    P01857    P01860    P01861
• Immunoglobulin heavy constant alpha 1 / Homo sapiens    P01876
• Immunoglobulin heavy constant alpha 2 / Homo sapiens    P01877
• Immunoglobulin heavy constant gamma 2 / Homo sapiens    P01859
• Immunoglobulin heavy constant mu / Homo sapiens    P01871
• Immunoglobulin kappa chain V-I region CAR / Homo sapiens    P01596
• Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens    Q14624
• Lactotransferrin / Homo sapiens    P02788
• Laminin subunit beta-1 / Homo sapiens    P07942
• Lumican / Homo sapiens    P51884
• Lysosome-associated membrane glycoprotein 1 / Homo sapiens    P11279
• Lysosome-associated membrane glycoprotein 2 / Homo sapiens    P13473
• Membrane primary amine oxidase / Homo sapiens    Q16853
• Mesothelin / Homo sapiens    Q13421
• Metalloproteinase inhibitor 1 / Homo sapiens    P01033
• Microtubule-associated serine/threonine-protein kinase 1 / Homo sapiens    Q9Y2H9
• Mucin-5B / Homo sapiens    Q9HC84
• Multimerin-1 / Homo sapiens    Q13201
• Multiple epidermal growth factor-like domains protein 8 / Homo sapiens    Q7Z7M0
• Neuroendocrine convertase 2 / Homo sapiens    P16519
• Neuron navigator 2 / Homo sapiens    Q8IVL1
• Olfactomedin-like protein 3 / Homo sapiens    Q9NRN5
• Periostin / Homo sapiens    Q15063
• Plasma protease c1 inhibitor / Homo sapiens    P05155
• Platelet glycoprotein 4 / Homo sapiens    P16671
• Polymeric immunoglobulin receptor / Homo sapiens    P01833
• Prolactin-inducible protein / Homo sapiens    P12273
• Prolargin / Homo sapiens    P51888
• Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens    Q07954
• Prostaglandin-h2 d-isomerase / Homo sapiens    P41222
• Prostate-specific antigen (psa-1) / Homo sapiens    P07288
• Protein AMBP / Homo sapiens    P02760
• Prothrombin / Homo sapiens    P00734
• Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens    Q9BYF1
• Serine/threonine-protein phosphatase 6 regulatory subunit 3 / Homo sapiens    Q5H9R7
• Short transient receptor potential channel 6 / Homo sapiens    Q9Y210
• Thrombospondin-1 / Homo sapiens    P07996
• Type 2 lactosamine alpha-2,3-sialyltransferase / Homo sapiens    Q9Y274
• Tyrosine-protein kinase Mer / Homo sapiens    Q12866
• Uncharacterized protein from Serum / Homo sapiens
• Vitronectin / Homo sapiens    P04004
• Von willebrand factor / Homo sapiens    P04275
• Zinc-alpha-2-glycoprotein / Homo sapiens    P25311
• Fetal antigen 1 / Mus musculus    Q09163
• Low density lipoprotein receptor-related protein 2 / Rattus norvegicus    P98158
• Neuroligin 1 / Rattus norvegicus    Q62765
• Major seminal plasma glycoprotein psp-i / Sus scrofa    P35495
• Major seminal plasma glycoprotein psp-ii / Sus scrofa    P35496
• Immunoglobulin gamma / Gallus gallus
• Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)    P0DTC2
• Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)    P0DTC2

Source

• Amniotic Fluid (UBERON_0000173)  
• Blood Serum (UBERON_0001977)  
• Kidney (UBERON_0002113)   HEK293 (CVCL_0045)  
• Kidney (UBERON_0002113)   HEK293-EBNA (CVCL_6974)  
• Mammalian Vulva (UBERON_0000997)   A-431 (CVCL_0037)  
• Mammary Gland (UBERON_0001911)  
• Milk (UBERON_0001913)  
• Ovary (UBERON_0000992)   CHO (CVCL_0213)  
• Seminal Fluid (UBERON_0006530)  
• Umbilical Vein (UBERON_0002066)   HUVEC-C (CVCL_2959)   Endothelial Cell of Umbilical Vein (CL_0002618)  
• Umbilical Vein (UBERON_0002066)   Endothelial Cell of Umbilical Vein (CL_0002618)  
• Urine (UBERON_0001088)  
• Yolk Sac (UBERON_0001040)  
• FreeStyle 293-F (CVCL_D603)  
• HEK293 (CVCL_0045)  
• Erythrocyte (CL_0000232)   Plasma Membrane (GO_0005886)  
• Microsome (GO_0005792)  

Reported structure

• N-Linked / Complex / Structure 1049
• N-Linked / Complex / Structure 1149
• N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ 2 x Gal(b1-4) + NeuAc(a2-6)"
• N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-?)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x Gal(b1-4) + NeuAc(a2-6)"
• N-Linked / Complex / Hex(?1-?)HexNAc(?1-?)Man(a1-?)[NeuAc(?2-?)Hex(?1-?)HexNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ HexNAc"
• N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(b1-2)Man(a1-?)[Gal(b1-?)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc+"+ HexNAc"
• N-Linked / Complex / Structure 2857
• N-Linked / Hybrid / NeuAc(a2-6)Gal(b1-3)GalNAc(b1-4)GlcNAc(?1-?)[GlcNAc(?1-?)]Man(a1-?)[Man(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Undefined core / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc + " + 2x Hex + 3x HexNAc + Fuc + NeuAc "

Composition

• Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )

Disease

• Cancer, breast (DOID:1612)
• Carcinoma, Squamous cell (DOID:1749)
• COVID-19 (DOID:0080600)
• Healthy
• Hyperimmune condition
• IgE myeloma (DOID:9538)
• Myeloma, Multiple (DOID:9538)
• Prostate cancer (DOID:10283)
• Tumor, Endodermal Sinus (DOID:1911)

Reference

• Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
• Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
• Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
• Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
• Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
• Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
• Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
• Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
• Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
• Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
• Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4 (2014 - Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.) / Status : Reviewed
• Site-specific N-glycosylation analysis of human immunoglobulin E. (2014 - Plomp R, Hensbergen PJ, Rombouts Y, Zauner G, Dragan I, Koeleman CA, Deelder AM, Wuhrer M) / Status : Reviewed
• Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
• Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures (2013 - Strum JS1, Nwosu CC, Hua S, Kronewitter SR, Seipert RR, Bachelor RJ, An HJ, Lebrilla CB) / Status : Reviewed
• Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
• Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
• Site-specific N-glycosylation of chicken serum IgG. (2004 - Suzuki N, Lee YC) / Status : Reviewed
• Structural characterization of recombinant soluble rat neuroligin 1: mapping of secondary structure and glycosylation by mass spectrometry. (2004 - Hoffman RC, Jennings LL, Tsigelny I, Comoletti D, Flynn RE, Sudhof TC, Taylor P) / Status : Reviewed
• Characterization of the carbohydrate chains of the secreted form of the human epidermal growth factor receptor. (2000 - Stroop C, Weber W, Gerwig G, Nimtz M, Kamerling J, Vliegenthart J) / Status : Reviewed
• Characterization of the N-linked oligosaccharides of megalin (gp330) from rat kidney. (2000 - Morelle W, Haslam S, Ziak M, Roth J, Morris H, Dell A) / Status : Reviewed
• Structural characterization of the oligosaccharide chains of native and crystallized boar seminal plasma spermadhesin PSP-I and PSP-II glycoforms. (1999 - Nimtz M, Grabenhorst E, Conradt H, Sanz L, Calvete J) / Status : Reviewed
• Characterization of human vascular endothelial cadherin glycans. (1999 - Geyer H, Geyer R, Odenthal-Schnittler M, Schnittler H) / Status : Reviewed
• Glycosylation analysis and protein structure determination of murine fetal antigen 1 (mFA1)--the circulating gene product of the delta-like protein (dlk), preadipocyte factor 1 (Pref-1) and stromal-cell-derived protein 1 (SCP-1) cDNAs. (1997 - Krogh T, Bachmann E, Teisner B, Skjdt K, Hjrup P) / Status : Reviewed
• Fractionation and characterization of boar seminal plasma spermadhesion PSP-II glycoforms reveal the presence of uncommon N-acetylgalactosamine-containing N-linked oligosaccharides. (1997 - Solis D, Calvete J, Sanz L, Hettel C, Raida M, Diaz-Maurio T, Tpfer-Petersen E) / Status : Reviewed
• Three-dimensional elution mapping of pyridylaminated N-linked neutral and sialyl oligosaccharides. (1995 - Takahashi N, Nakagawa H, Fujikawa K, Kawamura Y, Tomiya N) / Status : Reviewed
• Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography. (1995 - Nakagawa H, Kawamura Y, Kato K, Shimada I, Arata Y, Takahashi N) / Status : Reviewed
• Site-specific characterization of glycoprotein carbohydrates by exoglycosidase digestion and laser desorption mass spectrometry. (1994 - Sutton C, O'Neill J, Cottrell J) / Status : Reviewed
• Sugar chain of alpha-fetoprotein produced in human yolk sac tumor. (1983 - Yamashita K, Hitoi A, Tsuchida Y, Nishi S, Kobata A) / Status : Reviewed
• Structures of the asparagine-linked sugar chains of glycophorin A. (1980 - Yoshima H, Furthmayr H, Kobata A) / Status : Reviewed

Reported glycosite

• Alpha-1-antitrypsin / Homo sapiens
  •        Asn-271
• Alpha-2-HS-glycoprotein / Homo sapiens
  •        Asn-156
• Alpha-2-macroglobulin / Homo sapiens
  •        Asn-1424
• Alpha-fetoprotein / Homo sapiens
  •        Asn-251
• Angiopoietin-related protein 6 / Homo sapiens
  •        Asn-58
• Anoctamin-6 / Homo sapiens
  •        Asn-361
• Asporin / Homo sapiens
  •        Asn-282
• Beta/gamma crystallin domain-containing protein 1 / Homo sapiens
  •        Asn-1462
• Biglycan / Homo sapiens
  •        Asn-270
  •        Asn-311
• Cadherin-5 / Homo sapiens
  •        Undefined site
• Calumenin / Homo sapiens
  •        Asn-131
• Cartilage oligomeric matrix protein / Homo sapiens
  •        Asn-121
• Catalase / Homo sapiens
  •        Asn-481
• CD166 antigen / Homo sapiens
  •        Asn-306
• CD44 antigen / Homo sapiens
  •        Asn-57
• CD59 glycoprotein / Homo sapiens
  •        Asn-43
• Ceruloplasmin / Homo sapiens
  •        Asn-762
• Clusterin / Homo sapiens
  •        Asn-103
  •        Asn-374
• Collagen alpha-1(XII) chain / Homo sapiens
  •        Asn-2679
• Collagen alpha-2(VI) chain / Homo sapiens
  •        Asn-785
• Complement c1r subcomponent / Homo sapiens
  •        Asn-122
• Complement C2 / Homo sapiens
  •        Asn-651
• Complement C5 / Homo sapiens
  •        Asn-1115
• Corticosteroid-binding globulin / Homo sapiens
  •        Asn-31
• Decorin / Homo sapiens
  •        Asn-262
  •        Asn-303
• Dipeptidyl peptidase 1 / Homo sapiens
  •        Asn-276
• Ectopic P granules protein 5 homolog / Homo sapiens
  •        Asn-137
• Ephrin-A3 / Homo sapiens
  •        Asn-100
• Epidermal growth factor receptor / Homo sapiens
  •        Undefined site
• Fibrillin-1 / Homo sapiens
  •        Asn-1581
• Fibromodulin / Homo sapiens
  •        Asn-166
• Fibronectin / Homo sapiens
  •        Asn-430
  •        Asn-528
• Glycophorin-A / Homo sapiens
  •        Undefined site
• Golgi membrane protein 1 / Homo sapiens
  •        Asn-109
• Hemopexin / Homo sapiens
  •        Asn-453
• Heparin cofactor 2 / Homo sapiens
  •        Asn-49
  •        Asn-188
• Immunoglobulin epsilon chain c region / Homo sapiens
  •        Asn-21
  •        Asn-49
  •        Asn-99
  •        Asn-146
  •        Asn-252
• Immunoglobulin gamma / Homo sapiens
  •        Undefined site
• Immunoglobulin heavy constant alpha 1 / Homo sapiens
  •        Asn-144
  •        Asn-340
• Immunoglobulin heavy constant alpha 2 / Homo sapiens
  •        Asn-47
  •        Asn-92
  •        Asn-131
  •        Asn-205
• Immunoglobulin heavy constant gamma 2 / Homo sapiens
  •        Asn-176
• Immunoglobulin heavy constant mu / Homo sapiens
  •        Asn-46
  •        Asn-209
• Immunoglobulin kappa chain V-I region CAR / Homo sapiens
  •        Asn-28
• Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
  •        Asn-517
• Lactotransferrin / Homo sapiens
  •        Asn-497
• Laminin subunit beta-1 / Homo sapiens
  •        Asn-1279
• Lumican / Homo sapiens
  •        Asn-88
  •        Asn-127
• Lysosome-associated membrane glycoprotein 1 / Homo sapiens
  •        Asn-84
  •        Asn-249
• Lysosome-associated membrane glycoprotein 2 / Homo sapiens
  •        Asn-257
• Membrane primary amine oxidase / Homo sapiens
  •        Asn-592
  •        Asn-618
• Mesothelin / Homo sapiens
  •        Asn-494
• Metalloproteinase inhibitor 1 / Homo sapiens
  •        Asn-53
• Microtubule-associated serine/threonine-protein kinase 1 / Homo sapiens
  •        Asn-11
• Mucin-5B / Homo sapiens
  •        Asn-805
• Multimerin-1 / Homo sapiens
  •        Asn-828
• Multiple epidermal growth factor-like domains protein 8 / Homo sapiens
  •        Asn-421
• Neuroendocrine convertase 2 / Homo sapiens
  •        Asn-524
• Neuron navigator 2 / Homo sapiens
  •        Asn-1240
• Olfactomedin-like protein 3 / Homo sapiens
  •        Asn-248
• Periostin / Homo sapiens
  •        Asn-599
• Plasma protease c1 inhibitor / Homo sapiens
  •        Asn-25
  •        Asn-238
• Platelet glycoprotein 4 / Homo sapiens
  •        Asn-79
• Polymeric immunoglobulin receptor / Homo sapiens
  •        Asn-135
  •        Asn-186
  •        Asn-421
• Prolactin-inducible protein / Homo sapiens
  •        Asn-105
• Prolargin / Homo sapiens
  •        Asn-124
• Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
  •        Asn-729
  •        Asn-1825
• Prostaglandin-h2 d-isomerase / Homo sapiens
  •        Asn-51
  •        Asn-78
• Prostate-specific antigen (psa-1) / Homo sapiens
  •        Asn-69
• Protein AMBP / Homo sapiens
  •        Asn-250
• Prothrombin / Homo sapiens
  •        Asn-416
• Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens
  •        Undefined site
  •        Asn-322
  •        Asn-432
• Serine/threonine-protein phosphatase 6 regulatory subunit 3 / Homo sapiens
  •        Asn-682
• Short transient receptor potential channel 6 / Homo sapiens
  •        Asn-473
• Thrombospondin-1 / Homo sapiens
  •        Asn-360
• Type 2 lactosamine alpha-2,3-sialyltransferase / Homo sapiens
  •        Asn-308
• Tyrosine-protein kinase Mer / Homo sapiens
  •        Asn-442
  •        Asn-454
• Uncharacterized protein from Serum / Homo sapiens
  •        Undefined site
• Vitronectin / Homo sapiens
  •        Asn-169
• Von willebrand factor / Homo sapiens
  •        Asn-666
• Zinc-alpha-2-glycoprotein / Homo sapiens
  •        Asn-128
• Fetal antigen 1 / Mus musculus
  •        Asn-100
• Low density lipoprotein receptor-related protein 2 / Rattus norvegicus
  •        Undefined site
• Neuroligin 1 / Rattus norvegicus
  •        Undefined site
• Major seminal plasma glycoprotein psp-i / Sus scrofa
  •        Asn-71
• Major seminal plasma glycoprotein psp-ii / Sus scrofa
  •        Undefined site
  •        Asn-119
• Immunoglobulin gamma / Gallus gallus
  •        Undefined site
• Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
  •        Asn-17
  •        Asn-74
  •        Asn-331
  •        Asn-615
  •        Asn-1098
• Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
  •        Asn-122
  •        Asn-149
  •        Asn-165
  •        Asn-282
  •        Asn-331
  •        Asn-657

Mass spectrometry observed peptide

• SNFSMPSFPGGSMFR (15aa)
  •    Q9Y2H9    Asn-11
• QCVNLTTR (8aa)
  •    P0DTC2    Asn-17
• NPNATSSSSQDPESLQDR (18aa)
  •    P05155    Asn-25
• ASQNISSWLAWYQQK (15aa)
  •    P01596    Asn-28
• YVNMSNHHR (9aa)
  •    P08185    Asn-31
• TAVNCSSDFDACLITK (16aa)
  •    P13987    Asn-43
• YKNNSDISSTR (11aa)
  •    P01871    Asn-46
• SVTWSESGQNVTAR (14aa)
  •    P01877    Asn-47
• VFPLSLDSTPQDGNVVVACLVQGFFPQEPLSVTWSESGQNVTAR (44aa)
  •    P01877    Asn-47
• NLSMPLLPADFHK (13aa)
  •    P05546    Asn-49
• WFSAGLASNSSWLR (14aa)
  •    P41222    Asn-51
• AFNSTLPTMAQMEK (14aa)
  •    P16070    Asn-57
• ATPEAANASELAALR (15aa)
  •    Q8NI99    Asn-58
• SVVAPATDGGLNLTSTFLR (19aa)
  •    P41222    Asn-78
• HAIHVSGTNGTKRF (14aa)
  •    P0DTC2    Asn-74
• QFWIFDVQNPQEVMMNSSNIQVK (23aa)
  •    P16671    Asn-79
• SSCGKENTSDPSIVIAFGR (19aa)
  •    P11279    Asn-84
• AFENVTDLQWLILDHNLLENSK (22aa)
  •    P51884    Asn-88
• HYTNSSQDVTVPCR (14aa)
  •    P01877    Asn-92
• TCNASQGFK (9aa)
  •    P52797    Asn-100
• ELPGVCNETMMALWEECKPCLK (22aa)
  •    P10909    Asn-103
• TFYWDFYTNR (10aa)
  •    P12273    Asn-105
• AVIVNNITTGER (12aa)
  •    Q8NBJ4    Asn-109
• CGPCPAGFTGNGSHCTDVNECNAHPCFPR (29aa)
  •    P49747    Asn-121
• MLLTFHTDFSNEENGTIMFYK (21aa)
  •    P00736    Asn-122
• TQSLLIVNNATNVVIK (16aa)
  •    P0DTC2    Asn-122
• GWIFGTTLDSKTQSLLIVNNATNVVIK (27aa)
  •    P0DTC2    Asn-122
• LHINHNNLTESVGPLPK (17aa)
  •    P51884    Asn-127
• IHYLYLQNNFITELPVESFQNATGLR (26aa)
  •    P51888    Asn-124
• KLHINHNNLTESVGPLPK (18aa)
  •    P51884    Asn-127
• FGCEIENNR (9aa)
  •    P25311    Asn-128
• NATYGYVIDDPDPDDGFNYK (20aa)
  •    O43852    Asn-131
• LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
  •    P01876    Asn-144
• LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
  •    P01877    Asn-131
• GLSFDVSLEVSQGPGLLNDTK (21aa)
  •    P01833    Asn-135
• NFTEVEENMSVQGGLSESAPQSNFSYTQPAMENIQVR (37aa)
  •    Q9HCE0    Asn-137
• VCEFQFCNDPFLGVYYHKNNK (21aa)
  •    P0DTC2    Asn-149
• VCQDCPIIAPINDTR (15aa)
  •    P02765    Asn-156
• VYSSANNCTFE (11aa)
  •    P0DTC2    Asn-165
• IYIDHNNITR (10aa)
  •    Q06828    Asn-166
• NGSLFAFR (8aa)
  •    P04004    Asn-169
• EEQFNSTFR (9aa)
  •    P01859    Asn-176
• DFVNASSK (8aa)
  •    P05546    Asn-188
• TPLTANITK (9aa)
  •    P01877    Asn-205
• GLTFQQNASSMCGPDQDTAIR (21aa)
  •    P01871    Asn-209
  •    VAR_003904   215:V→G   dbSNP:rs12365
• GLTFQQNASSMCVPDQDTAIR (21aa)
  •    P01871    Asn-209
• GITFQQNASSMCVPDQDTAIR (21aa)
  •    P01871    Asn-209
• GLTFQQNASSM (11aa)
  •    P01871    Asn-209
• DTFVNASR (8aa)
  •    P05155    Asn-238
• FHLANR (6aa)
  •    Q9NRN5    Asn-248
• KDNTTVTR (8aa)
  •    P11279    Asn-249
• YFYNGTSMACETFQYGGCMGNGNNFVTEK (29aa)
  •    P02760    Asn-250
• VASVININPNTTHSTGSCR (19aa)
  •    P13473    Asn-257
• GLSFNSISAVDNGSLANTPHLR (22aa)
  •    P07585    Asn-262
• IGISFNSISAVDNGSIANTPHIR (23aa)
  •    P07585    Asn-262
• MIENGSISFIPTIR (14aa)
  •    P21810    Asn-270
• YLGNATAIFFLPDEGK (16aa)
  •    P01009    Asn-271
• IITNNSQTPIISPQEVVSCSQYAQGCEGGFPYIIAGK (37aa)
  •    P53634    Asn-276
• ITDIENGSIANIPR (14aa)
  •    Q9BXN1    Asn-282
• YNENGTITDAVDCALDPLSETK (22aa)
  •    P0DTC2    Asn-282
• NGTITDAVDCALDPLSE (17aa)
  •    P0DTC2    Asn-282
• YIQVVYLHNNNISVVGSSDFCPPGHNTK (28aa)
  •    P07585    Asn-303
• NATGDYK (7aa)
  •    Q13740    Asn-306
• NVTAEQLFLK (10aa)
  •    Q9Y274    Asn-308
• IIQVVYIHSNNITK (14aa)
  •    P21810    Asn-311
• VSVGLPNMTQGFW (13aa)
  •    Q9BYF1    Asn-322
• RFPNIT (6aa)
  •    P0DTC2    Asn-331
• FPNITNLCPFGE (12aa)
  •    P0DTC2    Asn-331
• LAGKPTHVNVS (11aa)
  •    P01876    Asn-340
• LAGKPTHVNVSVVMAEVDGTCY (22aa)
  •    P01876    Asn-340
• LAGKPTHVNVSVVMAEVDGTC (21aa)
  •    P01876    Asn-340
• IAGKPTHVNVSVVMAEVDGTCY (22aa)
  •    P01876    Asn-340
• KVSCPIMPCSNATVPDGECCPR (22aa)
  •    P07996    Asn-360
• LNITCESSK (9aa)
  •    Q4KMQ2    Asn-361
• IANITQGEDQYYIR (14aa)
  •    P10909    Asn-374
• CLLYPPWDKNFTENDLLVR (19aa)
  •    P00734    Asn-416
• NFTENDLLVR (10aa)
  •    P00734    Asn-416
• VNSTELFHVDR (11aa)
  •    Q7Z7M0    Asn-421
• NYTDCTSEGR (10aa)
  •    P02751    Asn-430
• SPDFQEDNETEINF (14aa)
  •    Q9BYF1    Asn-432
• SIGLLSPDFQEDNETEINF (19aa)
  •    Q9BYF1    Asn-432
• ELLEEVGQNGSR (12aa)
  •    Q12866    Asn-442
• AIPQPQNVTSIIGCTH (16aa)
  •    P02790    Asn-453
• ISVQVHNATCTVR (13aa)
  •    Q12866    Asn-454
• LLPNETSTDNAK (12aa)
  •    Q9Y210    Asn-473
• NFTEVHPDYGSHIQALLDK (19aa)
  •    P04040    Asn-481
• LAFQNMNGSEYFVK (14aa)
  •    Q13421    Asn-494
• TAGWNIPMGIIFNQTGSCK (19aa)
  •    P02788    Asn-497
• TAGWNIPMGLLFNQTGSCK (19aa)
  •    P02788    Asn-497
• NMTSPMGTK (9aa)
  •    P16519    Asn-524
• DQCIVDDITYNVNDTFHK (18aa)
  •    P02751    Asn-528
• YIYIASNHSNK (11aa)
  •    Q16853    Asn-592
• EVNDTLLVNELK (12aa)
  •    Q15063    Asn-599
• LYQDVNCT (8aa)
  •    P0DTC2    Asn-615
• IQMISFAGEPIPQNSSMAR (19aa)
  •    Q16853    Asn-618
• KTMFPNLTDVRE (12aa)
  •    P06681    Asn-651
• AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
  •    P0DTC2    Asn-657
• AGCLIGAEHVNNSYE (15aa)
  •    P0DTC2    Asn-657
• HVNNSYE (7aa)
  •    P0DTC2    Asn-657
• GQVYLQCGTPCNLTCR (16aa)
  •    P04275    Asn-666
• MEVDLSEPPNWSANFDVPMETTHGAPLDSVGSDVWSTEEPMPTK (44aa)
  •    Q5H9R7    Asn-682
• IETILLNGTDR (11aa)
  •    Q07954    Asn-729
• ELHHLQEQNVSNAFLDK (17aa)
  •    P00450    Asn-762
• NMTLFSDLVAEK (12aa)
  •    P12110    Asn-785
• STGCAAPMVYLDCSNSSAGTPGAECLR (27aa)
  •    Q9HC84    Asn-805
• NGTHWFV (7aa)
  •    P0DTC2    Asn-1098
• NGTHWFVT (8aa)
  •    P0DTC2    Asn-1098
• NYQLDNGSFKE (11aa)
  •    P01031    Asn-1115
• SSTSSIDSNISSK (13aa)
  •    Q8IVL1    Asn-1240
• LSDTTSQSNSTAK (13aa)
  •    P07942    Asn-1279
• VSNQTLSLFFTVLQDVPVR (19aa)
  •    P01023    Asn-1424
• VSGGSWVVYDGENFTGNQYVLEEGHYPCLSAMGCPPGATFK (41aa)
  •    Q9Y4K1    Asn-1462
• AWGTPCEMCPAVNTSEYK (18aa)
  •    P35555    Asn-1581
• NSTTLVMHMK (10aa)
  •    Q07954    Asn-1825
• EAGNITTDGYEIIGK (15aa)
  •    Q99715    Asn-2679